Compromised homologous recombination (HR) due to loss of BRCA1/2 is a dominant molecular feature of HGS ovarian cancer (The Cancer Genome Atlas Research Network 2011) and other epithelial malignancies (Yang et al. 2013). This evidence concerns the gene BRCA1 and ovarian carcinoma.